Personal CFO Solutions’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,500	Closed	-$322K	–	442
2020 Q4	$322K	Buy	+4,500	New	+$322K	0.08%	230